Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement

Philip Chen, Heng Xie, M. Chandra Sekar, Kiran Gupta, Alan Wells

Research output: Contribution to journalArticle

276 Citations (Scopus)

Abstract

We recently have demonstrated that EGF receptor (EGFR)-induced cell motility requires receptor kinase activity and autophosphorylation (P. Chen, K. Gupta, and A. Wells. 1994. J. Cell Biol. 124:547-555). This suggests that the immediate downstream effector molecule contains a src homology-2 domain. Phospholipase Cγ (PLCγ) is among the candidate transducers of this signal because of its potential roles in modulating cytoskeletal dynamics. We utilized signaling-restricted EGFR mutants expressed in receptor devoid NR6 cells to determine if PLC activation is necessary for EGFR-mediated cell movement. Exposure to EGF (25 nM) augmented PLC activity in all five EGFR mutant cell lines which also responded by increased cell movement. Basal phosphoinositide turnover was not affected by EGF in the lines which do not present the enhanced motility response. The correlation between EGFR-mediated cell motility and PLC activity suggested, but did not prove, a causal link. A specific inhibitor of PLC, U73122 (1 μM) diminished both the EGF-induced motility and PLC responses, while its inactive analogue U73343 had no effect on these responses. Both the PLC and motility responses were decreased by expression of a dominant-negative PLCγ-1 fragment in EGF-responsive infectant lines. Lastly, anti-sense oligonucleotides (20 μM) to PLCγ-1 reduced both responses in NR6 cells expressing wild-type EGFR. These findings strongly support PLCγ as the immediate post receptor effector in this motogenic pathway. We have demonstrated previously that EGFR-mediated cell motility and mitogenic signaling pathways are separable. The point of divergence is undefined. All kinase-active EGFR mutants induced the mitogenic response while only those which are autophosphorylated induced PLC activity. U73122 did not affect EGF-induced thymidine incorporation in these motility- responsive infectant cell lines. In addition, the dominant-negative PLCγ-1 fragment did not diminish EGF-induced thymidine incorporation. All kinase active EGFR stimulated mitogen-activated protein (MAP) kinase activity, regardless of whether the receptors induced cell movement; this EGF-induced MAP kinase activity was not affected by U73122 at concentrations that depressed the motility response. Thus, the signaling pathways which lead to motility and cell proliferation diverge at the immediate post-receptor stage, and we suggest that this is accomplished by differential activation of effector molecules.

Original languageEnglish
Pages (from-to)847-857
Number of pages11
JournalJournal of Cell Biology
Volume127
Issue number3
DOIs
StatePublished - Nov 9 1994

Fingerprint

Type C Phospholipases
Mitogen-Activated Protein Kinases
Epidermal Growth Factor Receptor
Cell Movement
Epidermal Growth Factor
Phosphotransferases
Thymidine
Cell Line
src Homology Domains
Antisense Oligonucleotides
Phosphatidylinositols
Transducers
Cell Proliferation

ASJC Scopus subject areas

  • Cell Biology

Cite this

Epidermal growth factor receptor-mediated cell motility : Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. / Chen, Philip; Xie, Heng; Sekar, M. Chandra; Gupta, Kiran; Wells, Alan.

In: Journal of Cell Biology, Vol. 127, No. 3, 09.11.1994, p. 847-857.

Research output: Contribution to journalArticle

@article{7efb144090604fe5ae98aa74906c664a,
title = "Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement",
abstract = "We recently have demonstrated that EGF receptor (EGFR)-induced cell motility requires receptor kinase activity and autophosphorylation (P. Chen, K. Gupta, and A. Wells. 1994. J. Cell Biol. 124:547-555). This suggests that the immediate downstream effector molecule contains a src homology-2 domain. Phospholipase Cγ (PLCγ) is among the candidate transducers of this signal because of its potential roles in modulating cytoskeletal dynamics. We utilized signaling-restricted EGFR mutants expressed in receptor devoid NR6 cells to determine if PLC activation is necessary for EGFR-mediated cell movement. Exposure to EGF (25 nM) augmented PLC activity in all five EGFR mutant cell lines which also responded by increased cell movement. Basal phosphoinositide turnover was not affected by EGF in the lines which do not present the enhanced motility response. The correlation between EGFR-mediated cell motility and PLC activity suggested, but did not prove, a causal link. A specific inhibitor of PLC, U73122 (1 μM) diminished both the EGF-induced motility and PLC responses, while its inactive analogue U73343 had no effect on these responses. Both the PLC and motility responses were decreased by expression of a dominant-negative PLCγ-1 fragment in EGF-responsive infectant lines. Lastly, anti-sense oligonucleotides (20 μM) to PLCγ-1 reduced both responses in NR6 cells expressing wild-type EGFR. These findings strongly support PLCγ as the immediate post receptor effector in this motogenic pathway. We have demonstrated previously that EGFR-mediated cell motility and mitogenic signaling pathways are separable. The point of divergence is undefined. All kinase-active EGFR mutants induced the mitogenic response while only those which are autophosphorylated induced PLC activity. U73122 did not affect EGF-induced thymidine incorporation in these motility- responsive infectant cell lines. In addition, the dominant-negative PLCγ-1 fragment did not diminish EGF-induced thymidine incorporation. All kinase active EGFR stimulated mitogen-activated protein (MAP) kinase activity, regardless of whether the receptors induced cell movement; this EGF-induced MAP kinase activity was not affected by U73122 at concentrations that depressed the motility response. Thus, the signaling pathways which lead to motility and cell proliferation diverge at the immediate post-receptor stage, and we suggest that this is accomplished by differential activation of effector molecules.",
author = "Philip Chen and Heng Xie and Sekar, {M. Chandra} and Kiran Gupta and Alan Wells",
year = "1994",
month = "11",
day = "9",
doi = "10.1083/jcb.127.3.847",
language = "English",
volume = "127",
pages = "847--857",
journal = "Journal of Cell Biology",
issn = "0021-9525",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - Epidermal growth factor receptor-mediated cell motility

T2 - Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement

AU - Chen, Philip

AU - Xie, Heng

AU - Sekar, M. Chandra

AU - Gupta, Kiran

AU - Wells, Alan

PY - 1994/11/9

Y1 - 1994/11/9

N2 - We recently have demonstrated that EGF receptor (EGFR)-induced cell motility requires receptor kinase activity and autophosphorylation (P. Chen, K. Gupta, and A. Wells. 1994. J. Cell Biol. 124:547-555). This suggests that the immediate downstream effector molecule contains a src homology-2 domain. Phospholipase Cγ (PLCγ) is among the candidate transducers of this signal because of its potential roles in modulating cytoskeletal dynamics. We utilized signaling-restricted EGFR mutants expressed in receptor devoid NR6 cells to determine if PLC activation is necessary for EGFR-mediated cell movement. Exposure to EGF (25 nM) augmented PLC activity in all five EGFR mutant cell lines which also responded by increased cell movement. Basal phosphoinositide turnover was not affected by EGF in the lines which do not present the enhanced motility response. The correlation between EGFR-mediated cell motility and PLC activity suggested, but did not prove, a causal link. A specific inhibitor of PLC, U73122 (1 μM) diminished both the EGF-induced motility and PLC responses, while its inactive analogue U73343 had no effect on these responses. Both the PLC and motility responses were decreased by expression of a dominant-negative PLCγ-1 fragment in EGF-responsive infectant lines. Lastly, anti-sense oligonucleotides (20 μM) to PLCγ-1 reduced both responses in NR6 cells expressing wild-type EGFR. These findings strongly support PLCγ as the immediate post receptor effector in this motogenic pathway. We have demonstrated previously that EGFR-mediated cell motility and mitogenic signaling pathways are separable. The point of divergence is undefined. All kinase-active EGFR mutants induced the mitogenic response while only those which are autophosphorylated induced PLC activity. U73122 did not affect EGF-induced thymidine incorporation in these motility- responsive infectant cell lines. In addition, the dominant-negative PLCγ-1 fragment did not diminish EGF-induced thymidine incorporation. All kinase active EGFR stimulated mitogen-activated protein (MAP) kinase activity, regardless of whether the receptors induced cell movement; this EGF-induced MAP kinase activity was not affected by U73122 at concentrations that depressed the motility response. Thus, the signaling pathways which lead to motility and cell proliferation diverge at the immediate post-receptor stage, and we suggest that this is accomplished by differential activation of effector molecules.

AB - We recently have demonstrated that EGF receptor (EGFR)-induced cell motility requires receptor kinase activity and autophosphorylation (P. Chen, K. Gupta, and A. Wells. 1994. J. Cell Biol. 124:547-555). This suggests that the immediate downstream effector molecule contains a src homology-2 domain. Phospholipase Cγ (PLCγ) is among the candidate transducers of this signal because of its potential roles in modulating cytoskeletal dynamics. We utilized signaling-restricted EGFR mutants expressed in receptor devoid NR6 cells to determine if PLC activation is necessary for EGFR-mediated cell movement. Exposure to EGF (25 nM) augmented PLC activity in all five EGFR mutant cell lines which also responded by increased cell movement. Basal phosphoinositide turnover was not affected by EGF in the lines which do not present the enhanced motility response. The correlation between EGFR-mediated cell motility and PLC activity suggested, but did not prove, a causal link. A specific inhibitor of PLC, U73122 (1 μM) diminished both the EGF-induced motility and PLC responses, while its inactive analogue U73343 had no effect on these responses. Both the PLC and motility responses were decreased by expression of a dominant-negative PLCγ-1 fragment in EGF-responsive infectant lines. Lastly, anti-sense oligonucleotides (20 μM) to PLCγ-1 reduced both responses in NR6 cells expressing wild-type EGFR. These findings strongly support PLCγ as the immediate post receptor effector in this motogenic pathway. We have demonstrated previously that EGFR-mediated cell motility and mitogenic signaling pathways are separable. The point of divergence is undefined. All kinase-active EGFR mutants induced the mitogenic response while only those which are autophosphorylated induced PLC activity. U73122 did not affect EGF-induced thymidine incorporation in these motility- responsive infectant cell lines. In addition, the dominant-negative PLCγ-1 fragment did not diminish EGF-induced thymidine incorporation. All kinase active EGFR stimulated mitogen-activated protein (MAP) kinase activity, regardless of whether the receptors induced cell movement; this EGF-induced MAP kinase activity was not affected by U73122 at concentrations that depressed the motility response. Thus, the signaling pathways which lead to motility and cell proliferation diverge at the immediate post-receptor stage, and we suggest that this is accomplished by differential activation of effector molecules.

UR - http://www.scopus.com/inward/record.url?scp=0028089832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028089832&partnerID=8YFLogxK

U2 - 10.1083/jcb.127.3.847

DO - 10.1083/jcb.127.3.847

M3 - Article

C2 - 7962064

AN - SCOPUS:0028089832

VL - 127

SP - 847

EP - 857

JO - Journal of Cell Biology

JF - Journal of Cell Biology

SN - 0021-9525

IS - 3

ER -